Supernus Pharmaceuticals | SUPN - Resultado Líquido





Resultado Líquido Alterar Data
Abbott USD 928M 149M 2026-06
ANI Pharmaceuticals USD 24.71M 4.78M 2026-06
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Canopy Growth CAD -157.11M 94.49M 2026-03
Cara Therapeutics USD -6.8M 1.28M 2026-03
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Novo Nordisk DKK 20.99B 5.9B 2026-06
Pacira USD 4.65M 1.74M 2026-06
Perrigo USD 74.5M 473.1M 2026-06
Pfizer USD -248M 2.94B 2026-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
United Therapeutics USD 333M 58.1M 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03